biote Statistics
Total Valuation
biote has a market cap or net worth of $131.51 million. The enterprise value is $219.81 million.
Important Dates
The next confirmed earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
biote has 45.82 million shares outstanding. The number of shares has increased by 7.32% in one year.
| Current Share Class | 31.69M |
| Shares Outstanding | 45.82M |
| Shares Change (YoY) | +7.32% |
| Shares Change (QoQ) | -14.10% |
| Owned by Insiders (%) | 28.78% |
| Owned by Institutions (%) | 46.07% |
| Float | 15.74M |
Valuation Ratios
The trailing PE ratio is 3.26 and the forward PE ratio is 11.33.
| PE Ratio | 3.26 |
| Forward PE | 11.33 |
| PS Ratio | 0.48 |
| Forward PS | 0.65 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.78 |
| P/OCF Ratio | 3.17 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 5.31, with an EV/FCF ratio of 6.31.
| EV / Earnings | 7.02 |
| EV / Sales | 1.10 |
| EV / EBITDA | 5.31 |
| EV / EBIT | 5.50 |
| EV / FCF | 6.31 |
Financial Position
The company has a current ratio of 0.98
| Current Ratio | 0.98 |
| Quick Ratio | 0.57 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.56 |
| Debt / FCF | 3.10 |
| Interest Coverage | 3.19 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 25.27% |
| Return on Invested Capital (ROIC) | 510.38% |
| Return on Capital Employed (ROCE) | 73.65% |
| Revenue Per Employee | $917,387 |
| Profits Per Employee | $144,276 |
| Employee Count | 217 |
| Asset Turnover | 2.01 |
| Inventory Turnover | 2.80 |
Taxes
In the past 12 months, biote has paid $2.26 million in taxes.
| Income Tax | 2.26M |
| Effective Tax Rate | 5.92% |
Stock Price Statistics
The stock price has decreased by -43.95% in the last 52 weeks. The beta is 1.16, so biote's price volatility has been higher than the market average.
| Beta (5Y) | 1.16 |
| 52-Week Price Change | -43.95% |
| 50-Day Moving Average | 3.10 |
| 200-Day Moving Average | 3.79 |
| Relative Strength Index (RSI) | 46.57 |
| Average Volume (20 Days) | 109,495 |
Short Selling Information
The latest short interest is 894,137, so 1.95% of the outstanding shares have been sold short.
| Short Interest | 894,137 |
| Short Previous Month | 931,798 |
| Short % of Shares Out | 1.95% |
| Short % of Float | 5.68% |
| Short Ratio (days to cover) | 8.29 |
Income Statement
In the last 12 months, biote had revenue of $199.07 million and earned $31.31 million in profits. Earnings per share was $0.88.
| Revenue | 199.07M |
| Gross Profit | 143.27M |
| Operating Income | 39.97M |
| Pretax Income | 38.17M |
| Net Income | 31.31M |
| EBITDA | 41.38M |
| EBIT | 39.97M |
| Earnings Per Share (EPS) | $0.88 |
Full Income StatementBalance Sheet
The company has $19.60 million in cash and $107.89 million in debt, giving a net cash position of -$88.29 million or -$1.93 per share.
| Cash & Cash Equivalents | 19.60M |
| Total Debt | 107.89M |
| Net Cash | -88.29M |
| Net Cash Per Share | -$1.93 |
| Equity (Book Value) | -78.84M |
| Book Value Per Share | -2.69 |
| Working Capital | -1.03M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $41.48 million and capital expenditures -$6.66 million, giving a free cash flow of $34.82 million.
| Operating Cash Flow | 41.48M |
| Capital Expenditures | -6.66M |
| Free Cash Flow | 34.82M |
| FCF Per Share | $0.76 |
Full Cash Flow StatementMargins
Gross margin is 71.97%, with operating and profit margins of 20.08% and 15.73%.
| Gross Margin | 71.97% |
| Operating Margin | 20.08% |
| Pretax Margin | 19.17% |
| Profit Margin | 15.73% |
| EBITDA Margin | 20.79% |
| EBIT Margin | 20.08% |
| FCF Margin | 17.49% |
Dividends & Yields
biote does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.32% |
| Shareholder Yield | -7.32% |
| Earnings Yield | 23.81% |
| FCF Yield | 26.48% |
Analyst Forecast
The average price target for biote is $6.00, which is 109.06% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.00 |
| Price Target Difference | 109.06% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 7.38% |
| EPS Growth Forecast (5Y) | 70.73% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
biote has an Altman Z-Score of 2.61 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.61 |
| Piotroski F-Score | 7 |
